GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » Construction In Progress

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Construction In Progress : ¥272.4 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co Construction In Progress?

Zhejiang Shengda Bio-Pharm Co's quarterly construction in progress increased from Sep. 2023 (¥202.2 Mil) to Dec. 2023 (¥247.3 Mil) and increased from Dec. 2023 (¥247.3 Mil) to Mar. 2024 (¥272.4 Mil).

Zhejiang Shengda Bio-Pharm Co's annual construction in progress increased from Dec. 2021 (¥88.8 Mil) to Dec. 2022 (¥93.3 Mil) and increased from Dec. 2022 (¥93.3 Mil) to Dec. 2023 (¥247.3 Mil).


Zhejiang Shengda Bio-Pharm Co Construction In Progress Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co Construction In Progress Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.19 61.42 88.76 93.33 247.32

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.13 165.75 202.20 247.32 272.35

Zhejiang Shengda Bio-Pharm Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
Executives
Pang Ai Ming Director
Zhu Yong Gang Director

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Headlines

No Headlines